Breaking Down China Nuclear Engineering Corporation Limited Financial Health: Key Insights for Investors

Breaking Down China Nuclear Engineering Corporation Limited Financial Health: Key Insights for Investors

CN | Industrials | Engineering & Construction | SHH

China Nuclear Engineering Corporation Limited (601611.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious investors will want to weigh a Q3 revenue of 20.47 billion CNY (down 15.78% sequentially) against a trailing twelve-month revenue of 108.55 billion CNY (Y/Y -1.07%) and 2024 annual sales of 113.54 billion CNY (+3.80% vs. 2023), while a market cap of 36.53 billion CNY (share price 12.69 CNY as of Dec 19, 2025) sits beside a modest TTM net income of 1.72 billion CNY (EPS 0.51 CNY) and ROE of 5.39%; profitability is thin with a net margin of 1.58% and EBITDA of 9.28 billion CNY even as the stock trades at a P/E of 23.55, forward P/E 14.87 and EV/EBITDA of 26.32 - valuation signals that contrast with a heavy balance sheet featuring a debt-to-equity ratio of 190.6% and enterprise value of 121.69 billion CNY, offset partially by 15.43 billion CNY in cash and cash equivalents (up 23.79%) but strained by 133.84 billion CNY in accounts receivable; add a dividend yield of 0.82% (0.10 CNY annualized), a P/S of 0.34 and P/B of 1.08, and growth vectors such as a 46% Y/Y jump in renewable contracts in 1H23, international expansion and tech-driven opportunities that could reshape revenue mix and risk exposure.

China Nuclear Engineering Corporation Limited (601611.SS) - Revenue Analysis

China Nuclear Engineering Corporation Limited reported mixed topline signals through 2024-2025, with quarterly softness in Q3 2025 offsetting an annual gain in 2024 but leaving trailing figures slightly down year-over-year.
  • Q3 2025 revenue: 20.47 billion CNY (down 15.78% vs. previous quarter)
  • TTM revenue: 108.55 billion CNY (down 1.07% YoY)
  • 2024 annual revenue: 113.54 billion CNY (up 3.80% vs. 2023)
  • Revenue per employee: ~2.38 million CNY (45,686 employees)
  • Price-to-sales (P/S) ratio: 0.34
  • Market capitalization: 36.53 billion CNY; share price: 12.69 CNY (as of 19 Dec 2025)
Metric Value Period / Note
Q3 Revenue 20.47 billion CNY Q3 2025 (-15.78% QoQ)
TTM Revenue 108.55 billion CNY Trailing twelve months (-1.07% YoY)
Annual Revenue 113.54 billion CNY 2024 (+3.80% YoY vs. 2023)
Employees 45,686 Headcount
Revenue per Employee ~2.38 million CNY TTM revenue / employees
Price-to-Sales (P/S) 0.34 Market valuation relative to sales
Market Cap 36.53 billion CNY As of 19 Dec 2025
Share Price 12.69 CNY As of 19 Dec 2025
  • Quarterly volatility: the 15.78% QoQ drop in Q3 2025 is the principal driver behind the TTM dip despite a positive 2024 annual result.
  • Valuation context: a P/S of 0.34 implies the market values the company at ~34% of annual sales - a conservative multiple that may reflect execution, backlog realization timing, or sector risk pricing.
  • Operational scale: revenue per employee (~2.38M CNY) suggests moderate productivity for a heavy-engineering, construction-heavy contractor; workforce scale magnifies sensitivity to project cycles.
  • Investor signal: market cap of 36.53B CNY against TTM revenue of 108.55B CNY gives a quick enterprise-sales perspective consistent with the low P/S multiple.
Exploring China Nuclear Engineering Corporation Limited Investor Profile: Who's Buying and Why?

China Nuclear Engineering Corporation Limited (601611.SS) - Profitability Metrics

China Nuclear Engineering Corporation Limited (601611.SS) shows a profile of moderate profitability with low net margins but sizable EBITDA, reflecting scale in operations despite tight retained earnings. Key headline figures for the trailing twelve months and recent annualized data are summarized below.
  • Net income (TTM): 1.72 billion CNY
  • EPS (TTM): 0.51 CNY
  • Return on Equity (ROE): 5.39%
  • Dividend yield: 0.82% (annualized payout: 0.10 CNY per share)
  • Price-to-Earnings (P/E) ratio: 23.55
  • EBITDA: 9.28 billion CNY
  • Net profit margin: 1.58%
Metric Value Notes
Net Income (TTM) 1.72 billion CNY Absolute bottom-line profit over last 12 months
EPS (TTM) 0.51 CNY Basic earnings per share
ROE 5.39% Moderate return on shareholders' equity
Dividend Yield 0.82% Annualized payout: 0.10 CNY per share
P/E Ratio 23.55 Market valuation of earnings
EBITDA 9.28 billion CNY Operational earnings before non-cash and financing items
Net Profit Margin 1.58% Profit as a percentage of revenue
Operational implications for investors:
  • High EBITDA relative to net income implies significant depreciation, interest, or one-off charges are compressing net profit.
  • ROE at 5.39% signals modest efficiency in converting equity into profit compared with higher-return peers.
  • Low net margin (1.58%) suggests limited pricing power or high operating/financial costs relative to revenue.
  • P/E of 23.55 indicates the market is pricing growth or stability expectations into the stock despite thin margins.
  • Dividend yield (0.82%) is modest; the 0.10 CNY per-share payout is defensive but not a primary income attraction.
For deeper context on ownership, trading patterns and shareholder composition see: Exploring China Nuclear Engineering Corporation Limited Investor Profile: Who's Buying and Why?

China Nuclear Engineering Corporation Limited (601611.SS) - Debt vs. Equity Structure

China Nuclear Engineering Corporation Limited (601611.SS) presents a capital structure characterized by materially higher leverage relative to equity. The headline metrics below help frame the interaction between market valuation, balance-sheet leverage and per-share economics.
  • Debt-to-Equity Ratio: 190.6% (high leverage)
  • Enterprise Value (EV): 121.69 billion CNY
  • Market Capitalization: 36.53 billion CNY
  • Price-to-Book (P/B): 1.08
  • Return on Investment (ROI): 5.39%
  • Shares Outstanding: 3.01 billion
  • Forward P/E: 14.87
Metric Value Calculated / Notes
Market Capitalization 36.53 billion CNY Reported market cap
Enterprise Value (EV) 121.69 billion CNY EV = Market Cap + Net Debt (implied)
Implied Net Debt (EV - Market Cap) 85.16 billion CNY 121.69 - 36.53
Debt (implied from D/E = 190.6%) ≈69.65 billion CNY 36.53 × 1.906 = 69.65 (total debt implied by ratio)
Shares Outstanding 3.01 billion Reported
Implied Share Price (Market Cap / Shares) ≈12.13 CNY 36.53bn / 3.01bn
Implied Forward EPS (Price / Forward P/E) ≈0.82 CNY 12.13 / 14.87
Book Value per Share (Implied) ≈11.23 CNY Price / P/B = 12.13 / 1.08
ROI 5.39% Reported return on investment
  • Leverage context - a D/E of 190.6% implies total debt roughly 1.906× equity (≈69.65bn CNY based on current market cap), while EV - Market Cap implies net debt of ≈85.16bn CNY; reconciling these requires reviewing cash and minority/other adjustments on the balance sheet.
  • Per-share perspective - implied price ≈12.13 CNY, book value ≈11.23 CNY (P/B 1.08), forward EPS ≈0.82 CNY (forward P/E 14.87).
  • Profitability vs. capital costs - ROI at 5.39% should be weighed against financing costs on the company's elevated leverage and industry risk profile.
  • Valuation signals - market cap (36.53bn) vs. EV (121.69bn) highlights the substantial role of debt in the enterprise value calculation.
Mission Statement, Vision, & Core Values (2026) of China Nuclear Engineering Corporation Limited.

China Nuclear Engineering Corporation Limited (601611.SS) - Liquidity and Solvency

Key near-term liquidity and solvency data points for China Nuclear Engineering Corporation Limited (601611.SS) provide a mixed picture: healthy cash growth, very large accounts receivable, positive operating cash flow, and a continued (but small) dividend payout.

  • Cash and cash equivalents: 15.43 billion CNY (increase of 23.79% vs. prior period)
  • Accounts receivable: 133.84 billion CNY - substantial outstanding payments
  • Cash flow from operations: positive (company generates cash from core activities)
  • Interim dividend: 0.01 CNY per share (most recent)
  • Current ratio and quick ratio: not explicitly stated in disclosures here; calculable when full current assets and current liabilities are available
Metric Value Notes
Cash & Cash Equivalents 15.43 billion CNY Up 23.79% from prior period
Accounts Receivable 133.84 billion CNY Large receivables suggest working-capital pressure
Operating Cash Flow Positive Indicates core business generates cash
Interim Dividend 0.01 CNY / share Shows history of distributions
Current Ratio Not specified Calculate as Current Assets / Current Liabilities when both are disclosed
Quick Ratio Not specified Calculate as (Current Assets - Inventory) / Current Liabilities
  • Implications for liquidity management:
    • Strong cash increase (+23.79%) improves short-term buffer.
    • Very high accounts receivable (133.84 bn CNY) elevates credit and collection risk and can strain working capital despite cash growth.
    • Positive operating cash flow mitigates some concerns, but timing of receivable collections matters.
  • Solvency considerations:
    • Without disclosed total liabilities and equity here, leverage and debt-service metrics cannot be fully assessed.
    • Investors should obtain current liabilities, total debt, interest expense, and EBITDA to compute debt ratios (debt/EBITDA, debt/equity, interest coverage).
  • Dividend policy signal:
    • Continuing interim dividend of 0.01 CNY/share signals shareholder returns but magnitude is modest relative to balance-sheet scale.

For broader context on the company's strategy, ownership and how it generates revenue, see: China Nuclear Engineering Corporation Limited: History, Ownership, Mission, How It Works & Makes Money

China Nuclear Engineering Corporation Limited (601611.SS) - Valuation Analysis

China Nuclear Engineering Corporation Limited (601611.SS) currently trades at valuation multiples that indicate a premium on earnings while showing moderate asset valuation and a modest yield for income-focused investors. The stock has experienced meaningful intrayear volatility, trading between 7.84 CNY and 15.21 CNY over the past 52 weeks. For deeper company background and context, see China Nuclear Engineering Corporation Limited: History, Ownership, Mission, How It Works & Makes Money.
  • EV/EBITDA: 26.32 - implies investors pay a high premium for operating earnings.
  • P/E (trailing): 23.55 - reflects market expectations of continued earnings growth.
  • Forward P/E: 14.87 - indicates analysts/market expect improved earnings over the next 12 months.
  • P/B: 1.08 - company valued slightly above its book (net asset) value.
  • Dividend yield: 0.82% - provides a modest cash return to shareholders.
  • 52-week range: 7.84-15.21 CNY - highlights recent price volatility and trading bandwidth.
Metric Value Implication
EV / EBITDA 26.32 Premium valuation vs. peers; limited margin for downside if earnings disappoint
P / E (trailing) 23.55 Market pricing in growth; higher than many mature industrial peers
Forward P / E 14.87 Anticipated earnings expansion or re-rating expected
P / B 1.08 Near book value - balance-sheet assets largely reflected in market cap
Dividend Yield 0.82% Low yield; not a primary income play
52‑Week Price Range 7.84 - 15.21 CNY High volatility; potential trading opportunities or risk

China Nuclear Engineering Corporation Limited (601611.SS) - Risk Factors

  • Capital structure pressure: debt-to-equity ratio of 190.6% indicates leverage substantially above 1:1, raising refinancing, interest-servicing and covenant risks.
  • Profitability constraints: net profit margin is thin at 1.58%, leaving limited buffer against cost overruns, contract disputes or lower-than-expected project revenues.
  • Receivables concentration and liquidity: a high level of accounts receivable ties up cash and increases exposure to collection delays or bad-debt write-offs, which can strain short-term liquidity.
  • Industry and regulatory exposure: fluctuations in the nuclear power sector, delays in project approvals, policy shifts or evolving safety/regulatory requirements can materially affect project timelines and margins.
  • Market and macro sensitivity: economic downturns, reduced infrastructure spending or broader market volatility can depress new contract awards and recurring revenue.
  • Share-price volatility: 52-week trading range between 7.84 and 15.21 CNY reflects material market uncertainty and investor sentiment swings that can affect cost of equity and access to capital.
Key Metric Reported Value / Status
Debt-to-Equity Ratio 190.6%
Net Profit Margin 1.58%
Accounts Receivable High (elevated balance relative to operating cash flow)
52‑Week Price Range (CNY) 7.84 - 15.21
Sector Sensitivity High (regulatory, project approval and commodity/service cost exposure)
  • Operational risk: large-scale project execution in nuclear engineering carries schedule, cost and subcontractor performance risks; small margin means overruns quickly erode profit.
  • Liquidity and funding risk: high leverage plus slow receivables can force reliance on short-term borrowings or asset-backed financing at higher spreads.
  • Counterparty and concentration risk: delayed payments from government or state-owned customers amplify receivable risk; single large-project exposure can magnify negative outcomes.
  • Regulatory/legal risk: shifts in domestic energy policy, stricter environmental/safety standards or geopolitical pressures could change project economics or lead to remediation liabilities.
  • Market risk: falling investor confidence or broader market sell-offs can widen funding spreads, reduce equity access, and depress share price volatility already observed.
For additional context on the company's background, corporate structure and how it generates revenue, see: China Nuclear Engineering Corporation Limited: History, Ownership, Mission, How It Works & Makes Money

China Nuclear Engineering Corporation Limited (601611.SS) - Growth Opportunities

China Nuclear Engineering Corporation Limited (601611.SS) is positioned at the intersection of traditional nuclear EPC and accelerating low-carbon energy markets. Key growth drivers combine an immediate uptick in renewable contracts with a broader nuclear power cycle and international expansion possibilities.
  • Renewables expansion: 46% year-over-year increase in renewable energy contracts in 1H23, reflecting a deliberate diversification from pure nuclear EPC toward wind, solar and integrated energy projects.
  • Nuclear market cycle: China's renewed push for nuclear capacity (multiple new reactors planned through the 2020s) suggests higher domestic demand for CNCEC's core services in reactor construction, lifecycle maintenance and decommissioning engineering.
  • Internationalization: Early-stage overseas projects and bids signal potential to grow non-domestic revenue from ~5% of total revenue toward a target range of 10-20% over several years, depending on tender wins and JV formation.
  • Technology leverage: Advances in modular reactor design, digital engineering and construction optimization can increase gross margins by reducing build time and cost overruns on large EPC contracts.
  • Revenue diversification: A growing pipeline in industrial and civil engineering (infrastructure, industrial parks, public works) provides recurring non-nuclear project revenue and reduces single-market cyclicality.
  • Partnerships and JVs: Strategic alliances with equipment suppliers, foreign EPC firms and local developers can accelerate market entry and share project risk on large-scale international bids.
Opportunity Evidence / Metric Near-term Impact (0-2 years) Medium-term Impact (3-5 years)
Renewable energy contracts 46% YoY increase in contracts (1H23); renewables share of new contract awards ~12-18% Revenue lift in H2 2023 and 2024; incremental EBITDA contribution Renewables contribute materially to top-line stability and margin diversification
Nuclear new-build cycle Multiple new reactor starts planned nationally; CNCEC core EPC capabilities Higher tendering activity and order backlog growth Significant backlog conversion, higher utilization and improved operating leverage
International projects Current foreign revenue ~5% (pilot projects/JVs); pipeline of tenders in SE Asia/Africa Small revenue additions; learning curve and balance-sheet investments Potential 10-20% of revenue from overseas with successful JV wins
Technological advancements Adoption of modular construction and digital design tools; potential cost savings 3-8% Lower project overruns; improved bid competitiveness Higher margins and repeatable project models
Industrial & civil engineering Growing contract awards outside nuclear sector; pipeline across municipal and industrial clients Steadier cash flows; offset to nuclear project seasonality Balanced revenue mix with lower cyclicality
Strategic partnerships / JVs Ongoing alliance activity with equipment vendors and foreign EPC firms Shared risk on large projects; access to complementary capabilities Enhanced win rates and higher-value contract capture
  • Order backlog trends: Investors should track quarterly backlog growth - early indicators point to mid-to-high single-digit backlog expansion in late 2023 driven by renewables and municipal projects.
  • Margin drivers: Improved project selection, modularization and repeatable civil/industrial contracts can expand operating margins by several hundred basis points over time.
  • Balance-sheet needs: International expansion and large EPC projects may require incremental working capital and project financing; strategic JV structures can mitigate cash strain.
  • Key KPIs to monitor: contract win rate, backlog growth, renewables share of new contracts, international revenue share, gross/EBITDA margins, and capex/working-capital intensity.
China Nuclear Engineering Corporation Limited: History, Ownership, Mission, How It Works & Makes Money

DCF model

China Nuclear Engineering Corporation Limited (601611.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.